SignalGeneriX has grown out of several decades of industrial experience and consulting mainly in the UK. It was formed in Cyprus in 2004 with a vision to become a leader in delivering state-of-the-art Digital Signal Processing (DSP) solutions. The company is deeply involved in DSP research and development, and has amassed a broad portfolio of intellectual property rights covering core signal processing algorithms, telecommunication networks, and wireless sensor applications. SG is actively participating in various national and European projects in its area of expertise. The company has recently completed two FP-6 projects where applied its DSP expertise in the development of a new ultrasound biosensor for the early detection of prostate cancer (TAMIRUT - IST project), and exploited its advanced knowledge of smart antenna algorithms for the development an indoor wireless localisation system (RESOLUTION - IST project). SignalGeneriX secured two FP7 for the benefit of SME projects for developing the FPGA processing board and image processing algorithms of a portable asbestos detector device and for investigating ultra low-power wireless body-area-networks (Wear-a-BAN SME Association project). The company has also recently been awarded the EUREKA label for its participation in a Medea+ project in the area of high speed communications and a Eurostars project in the area of robotics. The most recent EU project that the company is involved in an FP7 integrated project in the area of medical body area networks. The company is also participating as coordinator or partner in various national projects, funded by the Research Promotion Foundation, in the area of wireless communications, image and video processing and compression, wireless sensor networks, infrastructure monitoring and NDE.

The Lynceus2Market project receives funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No. 636286.

Connect with Us on Facebook Connect with Us on Twitter